Corvus hawaiiensis isolate bCorHaw1 chromosome 14, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036359.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC125333464, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125333464, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
adhesion G-protein coupled receptor G4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
vestigial like family member 1, transcript variant X3
vestigial like family member 1, transcript variant X1
vestigial like family member 1, transcript variant X5
vestigial like family member 1, transcript variant X4
vestigial like family member 1, transcript variant X6
vestigial like family member 1, transcript variant X2
transcription cofactor vestigial-like protein 1 isoform X3
transcription cofactor vestigial-like protein 1 isoform X4
transcription cofactor vestigial-like protein 1 isoform X1
transcription cofactor vestigial-like protein 1 isoform X2
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X2
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X1
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X3
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X5
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X7
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X6
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X8
Rac/Cdc42 guanine nucleotide exchange factor 6, transcript variant X4
rho guanine nucleotide exchange factor 6 isoform X3
rho guanine nucleotide exchange factor 6 isoform X2
rho guanine nucleotide exchange factor 6 isoform X1
rho guanine nucleotide exchange factor 6 isoform X4
RNA binding motif protein X-linked, transcript variant X5
RNA binding motif protein X-linked, transcript variant X1
RNA binding motif protein X-linked, transcript variant X2
RNA binding motif protein X-linked, transcript variant X3
RNA binding motif protein X-linked, transcript variant X4
RNA-binding motif protein, X chromosome isoform X2
RNA-binding motif protein, X chromosome isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00270
transmembrane 9 superfamily member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane 9 superfamily member 2-like, transcript variant X2
transmembrane 9 superfamily member 2-like isoform X2
transmembrane 9 superfamily member 2-like isoform X1
transmembrane 9 superfamily member 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
transmembrane 9 superfamily member 2-like isoform X3
Zic family member 3, transcript variant X1
Zic family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibroblast growth factor 13, transcript variant X1
fibroblast growth factor 13, transcript variant X5
fibroblast growth factor 13, transcript variant X2
fibroblast growth factor 13, transcript variant X6
fibroblast growth factor 13, transcript variant X4
fibroblast growth factor 13, transcript variant X3
MCF.2 cell line derived transforming sequence, transcript variant X4
MCF.2 cell line derived transforming sequence, transcript variant X2
MCF.2 cell line derived transforming sequence, transcript variant X3
MCF.2 cell line derived transforming sequence, transcript variant X1
MCF.2 cell line derived transforming sequence, transcript variant X5
ATPase phospholipid transporting 11C, transcript variant X8
ATPase phospholipid transporting 11C, transcript variant X1
ATPase phospholipid transporting 11C, transcript variant X2
phospholipid-transporting ATPase IG isoform X6
phospholipid-transporting ATPase IG isoform X1
phospholipid-transporting ATPase IG isoform X2
ATPase phospholipid transporting 11C, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
phospholipid-transporting ATPase IG isoform X7
phospholipid-transporting ATPase IG isoform X4
ATPase phospholipid transporting 11C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
ATPase phospholipid transporting 11C, transcript variant X4
phospholipid-transporting ATPase IG isoform X5
phospholipid-transporting ATPase IG isoform X3
ADP ribosylation factor like GTPase 13A, transcript variant X4
ADP ribosylation factor like GTPase 13A, transcript variant X2
ADP ribosylation factor like GTPase 13A, transcript variant X3
ADP ribosylation factor like GTPase 13A, transcript variant X1
ADP-ribosylation factor-like protein 13A isoform X2
ADP-ribosylation factor-like protein 13A isoform X1
XK related X-linked, transcript variant X2
XK related X-linked, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cleavage stimulation factor subunit 2, transcript variant X3
cleavage stimulation factor subunit 2, transcript variant X2
cleavage stimulation factor subunit 2, transcript variant X1
cleavage stimulation factor subunit 2 isoform X3
cleavage stimulation factor subunit 2 isoform X2
cleavage stimulation factor subunit 2 isoform X1
tRNA methyltransferase 12 homolog, transcript variant X1
tRNA methyltransferase 12 homolog, transcript variant X2
tRNA wybutosine-synthesizing protein 2 homolog isoform X1
tRNA wybutosine-synthesizing protein 2 homolog isoform X2
synaptotagmin like 4, transcript variant X2
synaptotagmin like 4, transcript variant X1
sushi repeat containing protein X-linked 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125333318, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125333318, transcript variant X2
uncharacterized LOC125333491, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125333491, transcript variant X3
uncharacterized LOC125333491, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
diaphanous related formin 2, transcript variant X2
diaphanous related formin 2, transcript variant X3
diaphanous related formin 2, transcript variant X1
diaphanous related formin 2, transcript variant X4
uncharacterized LOC125333486, transcript variant X1
uncharacterized LOC125333486, transcript variant X2
uncharacterized LOC125333098, transcript variant X9
uncharacterized LOC125333098, transcript variant X7
uncharacterized LOC125333098, transcript variant X13
uncharacterized LOC125333098, transcript variant X11
uncharacterized LOC125333098, transcript variant X1
uncharacterized LOC125333098, transcript variant X2
uncharacterized LOC125333098, transcript variant X3
uncharacterized LOC125333098, transcript variant X17
uncharacterized LOC125333098, transcript variant X18
uncharacterized LOC125333098, transcript variant X12
uncharacterized LOC125333098, transcript variant X16
uncharacterized LOC125333098, transcript variant X14
uncharacterized LOC125333098, transcript variant X6
uncharacterized LOC125333098, transcript variant X10
uncharacterized LOC125333098, transcript variant X15
uncharacterized LOC125333098, transcript variant X5
uncharacterized protein LOC125333098 isoform X1
uncharacterized LOC125333098, transcript variant X4
uncharacterized protein LOC125333098 isoform X2
uncharacterized LOC125333098, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
protocadherin 11 X-linked, transcript variant X3
protocadherin 11 X-linked, transcript variant X1
protocadherin 11 X-linked, transcript variant X2
protocadherin 11 X-linked, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protocadherin 11 X-linked, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
kelch like family member 4, transcript variant X4
kelch like family member 4, transcript variant X3
kelch like family member 4, transcript variant X1
kelch like family member 4, transcript variant X2
dachshund family transcription factor 2, transcript variant X2
dachshund family transcription factor 2, transcript variant X1
CHM Rab escort protein, transcript variant X2
rab proteins geranylgeranyltransferase component A 1 isoform X2
CHM Rab escort protein, transcript variant X1
rab proteins geranylgeranyltransferase component A 1 isoform X1
POF1B actin binding protein, transcript variant X1
POF1B actin binding protein, transcript variant X2
POF1B actin binding protein, transcript variant X3
zinc finger protein 711, transcript variant X9
zinc finger protein 711, transcript variant X2
zinc finger protein 711, transcript variant X6
zinc finger protein 711, transcript variant X7
zinc finger protein 711, transcript variant X3
zinc finger protein 711, transcript variant X5
zinc finger protein 711, transcript variant X4
zinc finger protein 711, transcript variant X8
zinc finger protein 711, transcript variant X1
apolipoprotein O like, transcript variant X2
apolipoprotein O like, transcript variant X1
connector enhancer of kinase suppressor of ras 2-like, transcript variant X2
connector enhancer of kinase suppressor of ras 2-like, transcript variant X1
connector enhancer of kinase suppressor of ras 2-like isoform X2
connector enhancer of kinase suppressor of ras 2-like isoform X1
highly divergent homeobox, transcript variant X3
highly divergent homeobox, transcript variant X1
highly divergent homeobox, transcript variant X2
ribosomal protein S6 kinase A6, transcript variant X3
ribosomal protein S6 kinase alpha-6 isoform X3
ribosomal protein S6 kinase A6, transcript variant X4
ribosomal protein S6 kinase alpha-6 isoform X4
ribosomal protein S6 kinase A6, transcript variant X1
ribosomal protein S6 kinase A6, transcript variant X2
ribosomal protein S6 kinase alpha-6 isoform X1
ribosomal protein S6 kinase alpha-6 isoform X2
ribosomal protein S6 kinase A6, transcript variant X5
ribosomal protein S6 kinase A6, transcript variant X6
ribosomal protein S6 kinase alpha-6 isoform X6
ribosomal protein S6 kinase alpha-6 isoform X5
uncharacterized LOC125333468, transcript variant X1
uncharacterized LOC125333468, transcript variant X2
uncharacterized LOC125333468, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 3, transcription factor 4
transmembrane protein 182-like, transcript variant X3
transmembrane protein 182-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 182-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium/hydrogen exchanger 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/hydrogen exchanger 2-like, transcript variant X3
sodium/hydrogen exchanger 2-like, transcript variant X1
sodium/hydrogen exchanger 2-like isoform X2
sodium/hydrogen exchanger 2-like isoform X1
TLR adapter interacting with SLC15A4 on the lysosome-like, transcript variant X4
TLR adapter interacting with SLC15A4 on the lysosome-like, transcript variant X3
TLR adapter interacting with SLC15A4 on the lysosome-like, transcript variant X1
TLR adapter interacting with SLC15A4 on the lysosome-like, transcript variant X2
TLR adapter interacting with SLC15A4 on the lysosome-like
SH3 domain binding glutamate rich protein like
SH3 domain-binding glutamic acid-rich-like protein
high mobility group nucleosome binding domain 5, transcript variant X2
high mobility group nucleosome-binding domain-containing protein 5 isoform X2
high mobility group nucleosome binding domain 5, transcript variant X1
high mobility group nucleosome-binding domain-containing protein 5 isoform X1
uncharacterized LOC125333190, transcript variant X1
uncharacterized LOC125333190, transcript variant X2
uncharacterized LOC125333190, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125333190, transcript variant X4
bromodomain and WD repeat domain containing 3
bromodomain and WD repeat-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
terminal nucleotidyltransferase 5D, transcript variant X1
terminal nucleotidyltransferase 5D, transcript variant X2
T-box transcription factor 22, transcript variant X2
T-box transcription factor 22, transcript variant X1
T-box transcription factor TBX22 isoform X2
T-box transcription factor TBX22 isoform X1
G protein-coupled receptor 174, transcript variant X1
G protein-coupled receptor 174, transcript variant X2
putative P2Y purinoceptor 10, transcript variant X2
putative P2Y purinoceptor 10, transcript variant X1
lysophosphatidic acid receptor 4, transcript variant X1
lysophosphatidic acid receptor 4, transcript variant X2
G-protein coupled receptor 183-B-like, transcript variant X1
G-protein coupled receptor 183-B-like, transcript variant X3
G-protein coupled receptor 183-B-like, transcript variant X2
lysophosphatidic acid receptor 6-like isoform X2
C-X-C chemokine receptor type 5-like isoform X1
G-protein coupled receptor 183-B-like isoform X3
fibronectin type-III domain-containing protein 3a-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fibronectin type-III domain-containing protein 3a-like
TATA-box binding protein associated factor 9b
transcription initiation factor TFIID subunit 9B
RAB41, member RAS oncogene family, transcript variant X1
RAB41, member RAS oncogene family, transcript variant X3
RAB41, member RAS oncogene family, transcript variant X2
RAB41, member RAS oncogene family, transcript variant X4
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like, transcript variant X1
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like isoform X2
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like isoform X1
diacylglycerol O-acyltransferase 2-like, transcript variant X2
diacylglycerol O-acyltransferase 2-like, transcript variant X1
diacylglycerol O-acyltransferase 2-like isoform X2
diacylglycerol O-acyltransferase 2-like isoform X1
transforming growth factor beta activator LRRC32-like, transcript variant X2
transforming growth factor beta activator LRRC32-like, transcript variant X1
transforming growth factor beta activator LRRC32-like, transcript variant X3
transforming growth factor beta activator LRRC32-like isoform X2
transforming growth factor beta activator LRRC32-like isoform X1
transforming growth factor beta activator LRRC32-like isoform X3
uncharacterized LOC125332983, transcript variant X2
uncharacterized LOC125332983, transcript variant X3
uncharacterized LOC125332983, transcript variant X1
StAR related lipid transfer domain containing 8, transcript variant X1
StAR related lipid transfer domain containing 8, transcript variant X2
stAR-related lipid transfer protein 8 isoform X1
stAR-related lipid transfer protein 8 isoform X2
ectodysplasin A2 receptor, transcript variant X1
ectodysplasin A2 receptor, transcript variant X2
tumor necrosis factor receptor superfamily member 27
probable G-protein coupled receptor 83, transcript variant X4
probable G-protein coupled receptor 83, transcript variant X3
probable G-protein coupled receptor 83, transcript variant X5
probable G-protein coupled receptor 83, transcript variant X1
probable G-protein coupled receptor 83, transcript variant X2
probable G-protein coupled receptor 83 isoform X2
probable G-protein coupled receptor 83 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
V-set and immunoglobulin domain-containing protein 4-like, transcript variant X1
V-set and immunoglobulin domain-containing protein 4-like, transcript variant X2
V-set and immunoglobulin domain-containing protein 4-like, transcript variant X3
V-set and immunoglobulin domain-containing protein 4-like isoform X1
V-set and immunoglobulin domain-containing protein 4-like isoform X2
V-set and immunoglobulin domain-containing protein 4-like isoform X3
uncharacterized LOC125332972, transcript variant X2
uncharacterized LOC125332972, transcript variant X1
zinc finger C4H2-type containing, transcript variant X2
zinc finger C4H2-type containing, transcript variant X3
zinc finger C4H2 domain-containing protein isoform X2
zinc finger C4H2-type containing, transcript variant X1
zinc finger C4H2 domain-containing protein isoform X1
zinc finger C4H2-type containing, transcript variant X4
zinc finger C4H2 domain-containing protein isoform X3
four and a half LIM domains 1, transcript variant X3
four and a half LIM domains 1, transcript variant X1
four and a half LIM domains 1, transcript variant X2
four and a half LIM domains 1, transcript variant X5
four and a half LIM domains 1, transcript variant X4
four and a half LIM domains protein 1 isoform X2
four and a half LIM domains protein 1 isoform X1
four and a half LIM domains protein 1 isoform X4
four and a half LIM domains protein 1 isoform X3
integrator complex subunit 6-like, transcript variant X4
integrator complex subunit 6-like, transcript variant X3
integrator complex subunit 6-like, transcript variant X2
integrator complex subunit 6-like, transcript variant X1
integrator complex subunit 6-like, transcript variant X6
integrator complex subunit 6-like, transcript variant X5
integrator complex subunit 6-like isoform X4
integrator complex subunit 6-like isoform X3
integrator complex subunit 6-like isoform X2
integrator complex subunit 6-like isoform X1
integrator complex subunit 6-like, transcript variant X12
integrator complex subunit 6-like, transcript variant X7
integrator complex subunit 6-like, transcript variant X13
integrator complex subunit 6-like, transcript variant X10
integrator complex subunit 6-like, transcript variant X8
integrator complex subunit 6-like isoform X8
integrator complex subunit 6-like isoform X5
integrator complex subunit 6-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
integrator complex subunit 6-like, transcript variant X9
integrator complex subunit 6-like isoform X7
integrator complex subunit 6-like isoform X6
motile sperm domain containing 1, transcript variant X1
motile sperm domain containing 1, transcript variant X2
motile sperm domain-containing protein 1
P2R1A-PPP2R2A-interacting phosphatase regulator 1, transcript variant X2
P2R1A-PPP2R2A-interacting phosphatase regulator 1, transcript variant X1
P2R1A-PPP2R2A-interacting phosphatase regulator 1 isoform X2
P2R1A-PPP2R2A-interacting phosphatase regulator 1 isoform X1
PABIR family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
PABIR family member 2, transcript variant X2
PABIR family member 2, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
uncharacterized LOC125333445, transcript variant X2
uncharacterized LOC125333445, transcript variant X1
uncharacterized LOC125333445, transcript variant X3
hypoxanthine phosphoribosyltransferase 1
hypoxanthine-guanine phosphoribosyltransferase
uncharacterized LOC125333396, transcript variant X2
uncharacterized LOC125333396, transcript variant X1
PHD finger protein 6, transcript variant X1
PHD finger protein 6, transcript variant X2
muscleblind like splicing regulator 3, transcript variant X7
muscleblind like splicing regulator 3, transcript variant X2
muscleblind like splicing regulator 3, transcript variant X4
muscleblind like splicing regulator 3, transcript variant X5
muscleblind like splicing regulator 3, transcript variant X9
muscleblind like splicing regulator 3, transcript variant X8
muscleblind like splicing regulator 3, transcript variant X1
muscleblind like splicing regulator 3, transcript variant X10
muscleblind like splicing regulator 3, transcript variant X6
muscleblind like splicing regulator 3, transcript variant X11
muscleblind like splicing regulator 3, transcript variant X3
RAP2C, member of RAS oncogene family, transcript variant X2
RAP2C, member of RAS oncogene family, transcript variant X1
FERM domain containing 7, transcript variant X1
FERM domain containing 7, transcript variant X3
FERM domain containing 7, transcript variant X2
FERM domain containing 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FERM domain-containing protein 7 isoform X1
FERM domain-containing protein 7 isoform X3
FERM domain-containing protein 7 isoform X2
FERM domain-containing protein 7 isoform X4
endogenous retroviral envelope protein HEMO-like, transcript variant X2
endogenous retroviral envelope protein HEMO-like, transcript variant X3
endogenous retroviral envelope protein HEMO-like, transcript variant X1
endogenous retroviral envelope protein HEMO-like
angiotensin II receptor type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
angiotensin II receptor type 2, transcript variant X2
angiotensin II receptor type 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 6 member 14, transcript variant X3
solute carrier family 6 member 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 6 member 14, transcript variant X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) isoform X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein FAM162B-like
kelch like family member 13, transcript variant X9
kelch like family member 13, transcript variant X4
kelch like family member 13, transcript variant X5
kelch like family member 13, transcript variant X6
kelch like family member 13, transcript variant X7
kelch like family member 13, transcript variant X3
kelch like family member 13, transcript variant X1
kelch like family member 13, transcript variant X2
kelch like family member 13, transcript variant X8
WD repeat domain 44, transcript variant X2
WD repeat domain 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
WD repeat domain 44, transcript variant X1
WD repeat-containing protein 44 isoform X1
WD repeat-containing protein 44 isoform X2
WD repeat-containing protein 44 isoform X3
dedicator of cytokinesis 11, transcript variant X1
dedicator of cytokinesis 11, transcript variant X4
dedicator of cytokinesis 11, transcript variant X3
dedicator of cytokinesis 11, transcript variant X2
dedicator of cytokinesis 11, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X1
dedicator of cytokinesis protein 11 isoform X4
dedicator of cytokinesis protein 11 isoform X3
dedicator of cytokinesis protein 11 isoform X2
dedicator of cytokinesis protein 11 isoform X5
RPA1 related single stranded DNA binding protein, X-linked
Nik related kinase, transcript variant X4
Nik related kinase, transcript variant X3
Nik related kinase, transcript variant X2
Nik related kinase, transcript variant X5
Nik related kinase, transcript variant X1
Nik related kinase, transcript variant X6
Nik related kinase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
interleukin 1 receptor accessory protein like 2, transcript variant X7
interleukin 1 receptor accessory protein like 2, transcript variant X5
interleukin 1 receptor accessory protein like 2, transcript variant X1
interleukin 1 receptor accessory protein like 2, transcript variant X2
interleukin 1 receptor accessory protein like 2, transcript variant X4
interleukin 1 receptor accessory protein like 2, transcript variant X3
interleukin 1 receptor accessory protein like 2, transcript variant X8
interleukin 1 receptor accessory protein like 2, transcript variant X6
X-linked interleukin-1 receptor accessory protein-like 2 isoform X2
X-linked interleukin-1 receptor accessory protein-like 2 isoform X4
X-linked interleukin-1 receptor accessory protein-like 2 isoform X1
X-linked interleukin-1 receptor accessory protein-like 2 isoform X3
X-linked interleukin-1 receptor accessory protein-like 2 isoform X5
homeobox protein ARX-like, transcript variant X3
homeobox protein ARX-like, transcript variant X2
homeobox protein ARX-like, transcript variant X1
aristaless-related homeobox protein-like isoform X2
aristaless-related homeobox protein-like isoform X3
family with sequence similarity 199, X-linked
COMM domain containing 5, transcript variant X1
COMM domain containing 5, transcript variant X3
COMM domain containing 5, transcript variant X2
COMM domain-containing protein 5 isoform X1
COMM domain-containing protein 5 isoform X2
LON peptidase N-terminal domain and ring finger 3, transcript variant X1
LON peptidase N-terminal domain and ring finger 3, transcript variant X2
LON peptidase N-terminal domain and ring finger 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 3 isoform X1
LON peptidase N-terminal domain and RING finger protein 3 isoform X2
KIAA1210 ortholog, transcript variant X5
KIAA1210 ortholog, transcript variant X2
KIAA1210 ortholog, transcript variant X4
KIAA1210 ortholog, transcript variant X1
KIAA1210 ortholog, transcript variant X3
KIAA1210 ortholog, transcript variant X7
KIAA1210 ortholog, transcript variant X6
KIAA1210 ortholog, transcript variant X8
acrosomal protein KIAA1210 homolog isoform X2
acrosomal protein KIAA1210 homolog isoform X4
acrosomal protein KIAA1210 homolog isoform X1
acrosomal protein KIAA1210 homolog isoform X3
acrosomal protein KIAA1210 homolog isoform X5
progesterone receptor membrane component 1
membrane-associated progesterone receptor component 1
LOW QUALITY PROTEIN: ADP/ATP translocase 2
NFKB repressing factor, transcript variant X1
NFKB repressing factor, transcript variant X2
sosondowah ankyrin repeat domain family member D
ankyrin repeat domain-containing protein SOWAHD
COORDINATES: nucleotide motif:Rfam:12.0:RF00265
UPF3B regulator of nonsense mediated mRNA decay
NADH:ubiquinone oxidoreductase subunit A1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
zinc finger and BTB domain containing 33, transcript variant X1
transcriptional regulator Kaiso isoform X1
zinc finger and BTB domain containing 33, transcript variant X2
transcriptional regulator Kaiso isoform X2
transmembrane protein 255A, transcript variant X2
transmembrane protein 255A, transcript variant X1
ATPase Na+/K+ transporting family member beta 4, transcript variant X2
ATPase Na+/K+ transporting family member beta 4, transcript variant X1
ATPase Na+/K+ transporting family member beta 4, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysosome-associated membrane glycoprotein 2
C1GALT1 specific chaperone 1, transcript variant X1
C1GALT1 specific chaperone 1, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X4
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X5
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X1
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X3
glutamate ionotropic receptor AMPA type subunit 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
X-linked inhibitor of apoptosis, transcript variant X3
X-linked inhibitor of apoptosis, transcript variant X5
X-linked inhibitor of apoptosis, transcript variant X1
X-linked inhibitor of apoptosis, transcript variant X4
X-linked inhibitor of apoptosis, transcript variant X2
E3 ubiquitin-protein ligase XIAP isoform X2
E3 ubiquitin-protein ligase XIAP isoform X4
E3 ubiquitin-protein ligase XIAP isoform X1
E3 ubiquitin-protein ligase XIAP isoform X3
stromal antigen 2, transcript variant X4
stromal antigen 2, transcript variant X3
stromal antigen 2, transcript variant X1
stromal antigen 2, transcript variant X2
teneurin transmembrane protein 1, transcript variant X2
teneurin transmembrane protein 1, transcript variant X3
teneurin transmembrane protein 1, transcript variant X7
teneurin transmembrane protein 1, transcript variant X5
teneurin transmembrane protein 1, transcript variant X6
teneurin transmembrane protein 1, transcript variant X1
teneurin transmembrane protein 1, transcript variant X4
uncharacterized LOC125333435, transcript variant X1
uncharacterized LOC125333435, transcript variant X2
uncharacterized LOC125333435, transcript variant X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
probable global transcription activator SNF2L1
GRB2 associated binding protein 3, transcript variant X1
GRB2 associated binding protein 3, transcript variant X2
GRB2 associated binding protein 3, transcript variant X3
GRB2-associated-binding protein 3 isoform X1
GRB2-associated-binding protein 3 isoform X2
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X6
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X5
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein-like isoform X1
phosphatidylinositol-binding clathrin assembly protein-like isoform X3
phosphatidylinositol-binding clathrin assembly protein-like isoform X2
phosphatidylinositol-binding clathrin assembly protein-like isoform X4
phosphatidylinositol-binding clathrin assembly protein-like isoform X5
phosphatidylinositol-binding clathrin assembly protein-like isoform X6
phosphatidylinositol-binding clathrin assembly protein-like isoform X7
VHL binding protein 1, transcript variant X1
VHL binding protein 1, transcript variant X2
VHL binding protein 1, transcript variant X3
synaptotagmin-like protein 1, transcript variant X3
synaptotagmin-like protein 1, transcript variant X1
synaptotagmin-like protein 1, transcript variant X2
synaptotagmin-like protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
V-set and immunoglobulin domain containing 1, transcript variant X1
V-set and immunoglobulin domain containing 1, transcript variant X2
V-set and immunoglobulin domain-containing protein 1 isoform X1
V-set and immunoglobulin domain-containing protein 1 isoform X2
proteasome 26S subunit, non-ATPase 10, transcript variant X1
26S proteasome non-ATPase regulatory subunit 10 isoform X1
proteasome 26S subunit, non-ATPase 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 10 isoform X2
autophagy related 4A cysteine peptidase, transcript variant X1
autophagy related 4A cysteine peptidase, transcript variant X2
collagen type IV alpha 6 chain, transcript variant X2
collagen type IV alpha 6 chain, transcript variant X1
collagen type IV alpha 5 chain, transcript variant X1
collagen type IV alpha 5 chain, transcript variant X3
collagen type IV alpha 5 chain, transcript variant X4
collagen type IV alpha 5 chain, transcript variant X2
collagen type IV alpha 5 chain, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: insulin receptor substrate 4
uncharacterized LOC125333144, transcript variant X1
uncharacterized LOC125333144, transcript variant X2
nuclear transport factor 2 like export factor 2, transcript variant X3
nuclear transport factor 2 like export factor 2, transcript variant X2
NTF2-related export protein 2 isoform X3
NTF2-related export protein 2 isoform X2
nuclear transport factor 2 like export factor 2, transcript variant X4
nuclear transport factor 2 like export factor 2, transcript variant X1
NTF2-related export protein 2 isoform X1
NTF2-related export protein 2 isoform X4
potassium voltage-gated channel subfamily E regulatory subunit 5
potassium voltage-gated channel subfamily E regulatory beta subunit 5
acyl-CoA synthetase long chain family member 4, transcript variant X8
acyl-CoA synthetase long chain family member 4, transcript variant X5
acyl-CoA synthetase long chain family member 4, transcript variant X6
acyl-CoA synthetase long chain family member 4, transcript variant X7
acyl-CoA synthetase long chain family member 4, transcript variant X1
acyl-CoA synthetase long chain family member 4, transcript variant X4
acyl-CoA synthetase long chain family member 4, transcript variant X3
acyl-CoA synthetase long chain family member 4, transcript variant X2
long-chain-fatty-acid--CoA ligase 4 isoform X3
long-chain-fatty-acid--CoA ligase 4 isoform X2
long-chain-fatty-acid--CoA ligase 4 isoform X1
long-chain-fatty-acid--CoA ligase 4 isoform X4
transmembrane protein 164, transcript variant X2
transmembrane protein 164, transcript variant X1
AMMECR nuclear protein 1, transcript variant X1
AMME syndrome candidate gene 1 protein isoform X1
AMMECR nuclear protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AMME syndrome candidate gene 1 protein isoform X2
p21 (RAC1) activated kinase 3, transcript variant X6
p21 (RAC1) activated kinase 3, transcript variant X5
p21 (RAC1) activated kinase 3, transcript variant X8
p21 (RAC1) activated kinase 3, transcript variant X2
p21 (RAC1) activated kinase 3, transcript variant X7
p21 (RAC1) activated kinase 3, transcript variant X9
p21 (RAC1) activated kinase 3, transcript variant X1
p21 (RAC1) activated kinase 3, transcript variant X10
p21 (RAC1) activated kinase 3, transcript variant X3
p21 (RAC1) activated kinase 3, transcript variant X4
serine/threonine-protein kinase PAK 3 isoform X1
serine/threonine-protein kinase PAK 3 isoform X2
serine/threonine-protein kinase pim-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase pim-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
TBC1 domain family member 8B, transcript variant X1
TBC1 domain family member 8B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
TBC1 domain family member 8B, transcript variant X3
PAS domain containing repressor 1, transcript variant X3
PAS domain containing repressor 1, transcript variant X2
PAS domain containing repressor 1, transcript variant X4
PAS domain containing repressor 1, transcript variant X5
PAS domain containing repressor 1, transcript variant X1
PAS domain containing repressor 1, transcript variant X6
circadian clock protein PASD1 isoform X2
circadian clock protein PASD1 isoform X1
circadian clock protein PASD1 isoform X3
vacuolar ATPase assembly integral membrane protein VMA21
G protein-coupled receptor 50, transcript variant X1
G protein-coupled receptor 50, transcript variant X2
G protein-coupled receptor 50, transcript variant X4
G protein-coupled receptor 50, transcript variant X3
CD99 molecule like 2, transcript variant X2
CD99 molecule like 2, transcript variant X1
myotubularin related protein 1, transcript variant X2
myotubularin related protein 1, transcript variant X1
myotubularin related protein 1, transcript variant X9
myotubularin related protein 1, transcript variant X6
myotubularin related protein 1, transcript variant X8
myotubularin related protein 1, transcript variant X5
myotubularin related protein 1, transcript variant X4
myotubularin related protein 1, transcript variant X3
myotubularin related protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
mastermind-like domain-containing protein 1
uncharacterized LOC125333044, transcript variant X1
uncharacterized LOC125333044, transcript variant X2
iduronate 2-sulfatase, transcript variant X1
iduronate 2-sulfatase, transcript variant X2
uncharacterized LOC125333247, transcript variant X1
uncharacterized LOC125333247, transcript variant X2
uncharacterized LOC125333247, transcript variant X3
AF4/FMR2 family member 2, transcript variant X7
AF4/FMR2 family member 2, transcript variant X6
AF4/FMR2 family member 2, transcript variant X5
AF4/FMR2 family member 2, transcript variant X2
AF4/FMR2 family member 2, transcript variant X4
AF4/FMR2 family member 2, transcript variant X1
AF4/FMR2 family member 2, transcript variant X3
fragile X messenger ribonucleoprotein 1, transcript variant X8
fragile X messenger ribonucleoprotein 1, transcript variant X6
fragile X messenger ribonucleoprotein 1, transcript variant X4
fragile X messenger ribonucleoprotein 1, transcript variant X5
fragile X messenger ribonucleoprotein 1, transcript variant X2
fragile X messenger ribonucleoprotein 1, transcript variant X1
fragile X messenger ribonucleoprotein 1, transcript variant X3
synaptic functional regulator FMR1 isoform X6
synaptic functional regulator FMR1 isoform X4
synaptic functional regulator FMR1 isoform X2
synaptic functional regulator FMR1 isoform X3
synaptic functional regulator FMR1 isoform X1
synaptic functional regulator FMR1 isoform X5
synaptic functional regulator FMR1 isoform X8
fragile X messenger ribonucleoprotein 1, transcript variant X7
synaptic functional regulator FMR1 isoform X7
testis-specific serine/threonine-protein kinase 2-like
SLIT and NTRK like family member 2, transcript variant X2
SLIT and NTRK like family member 2, transcript variant X1
uncharacterized LOC125333040, transcript variant X9
uncharacterized LOC125333040, transcript variant X7
uncharacterized LOC125333040, transcript variant X8
uncharacterized LOC125333040, transcript variant X6
uncharacterized LOC125333040, transcript variant X10
uncharacterized LOC125333040, transcript variant X3
uncharacterized LOC125333040, transcript variant X4
uncharacterized LOC125333040, transcript variant X12
uncharacterized LOC125333040, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125333040, transcript variant X14
uncharacterized LOC125333040, transcript variant X1
uncharacterized LOC125333040, transcript variant X2
uncharacterized LOC125333040, transcript variant X5
uncharacterized LOC125333040, transcript variant X11
SLIT and NTRK like family member 4, transcript variant X4
SLIT and NTRK like family member 4, transcript variant X1
SLIT and NTRK like family member 4, transcript variant X3
SLIT and NTRK like family member 4, transcript variant X2
serine/threonine-protein kinase PAK 3-like
leucine-rich repeat and calponin homology domain-containing protein 2-like
UAP56-interacting factor-like, transcript variant X3
UAP56-interacting factor-like, transcript variant X2
UAP56-interacting factor-like, transcript variant X1
UAP56-interacting factor-like isoform X3
UAP56-interacting factor-like isoform X2
UAP56-interacting factor-like isoform X1
leucine-rich repeat and calponin homology domain-containing protein 2-like, transcript variant X1
leucine-rich repeat and calponin homology domain-containing protein 2-like, transcript variant X3
leucine-rich repeat and calponin homology domain-containing protein 2-like, transcript variant X2
leucine-rich repeat and calponin homology domain-containing protein 2-like, transcript variant X4
leucine-rich repeat and calponin homology domain-containing protein 2-like, transcript variant X5
leucine-rich repeat and calponin homology domain-containing protein 2-like isoform X1
leucine-rich repeat and calponin homology domain-containing protein 2-like isoform X3
leucine-rich repeat and calponin homology domain-containing protein 2-like isoform X2
leucine-rich repeat and calponin homology domain-containing protein 2-like isoform X4
leucine-rich repeat and calponin homology domain-containing protein 2-like isoform X5
interleukin 13 receptor subunit alpha 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
interleukin 13 receptor subunit alpha 2, transcript variant X6
interleukin-13 receptor subunit alpha-2 isoform X2
interleukin-13 receptor subunit alpha-2 isoform X1
uncharacterized LOC125333032, transcript variant X6
uncharacterized LOC125333032, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC125333032, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125333032, transcript variant X3
uncharacterized LOC125333032, transcript variant X9
uncharacterized LOC125333032, transcript variant X4
uncharacterized LOC125333032, transcript variant X7
uncharacterized LOC125333032, transcript variant X1
uncharacterized LOC125333032, transcript variant X5
5-hydroxytryptamine receptor 2C, transcript variant X2
5-hydroxytryptamine receptor 2C, transcript variant X6
5-hydroxytryptamine receptor 2C, transcript variant X1
5-hydroxytryptamine receptor 2C, transcript variant X3
5-hydroxytryptamine receptor 2C, transcript variant X5
5-hydroxytryptamine receptor 2C, transcript variant X4
5-hydroxytryptamine receptor 2C isoform X2
5-hydroxytryptamine receptor 2C isoform X1
glycerophosphodiester phosphodiesterase domain containing 2, transcript variant X2
glycerophosphodiester phosphodiesterase domain containing 2, transcript variant X1
glycerophosphodiester phosphodiesterase domain containing 2, transcript variant X3
glycerophosphoinositol inositolphosphodiesterase GDPD2 isoform X2
glycerophosphoinositol inositolphosphodiesterase GDPD2 isoform X1
discs large MAGUK scaffold protein 3, transcript variant X1
discs large MAGUK scaffold protein 3, transcript variant X2
discs large MAGUK scaffold protein 3, transcript variant X4
discs large MAGUK scaffold protein 3, transcript variant X3
discs large MAGUK scaffold protein 3, transcript variant X11
discs large MAGUK scaffold protein 3, transcript variant X12
discs large MAGUK scaffold protein 3, transcript variant X5
discs large MAGUK scaffold protein 3, transcript variant X8
discs large MAGUK scaffold protein 3, transcript variant X6
discs large MAGUK scaffold protein 3, transcript variant X7
discs large MAGUK scaffold protein 3, transcript variant X9
discs large MAGUK scaffold protein 3, transcript variant X10
discs large MAGUK scaffold protein 3, transcript variant X13
solute carrier family 7 member 3, transcript variant X1
solute carrier family 7 member 3, transcript variant X2
cationic amino acid transporter 3 isoform X1
cationic amino acid transporter 3 isoform X2
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like isoform X3
translation initiation factor IF-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
translation initiation factor IF-2-like isoform X2
translation initiation factor IF-2-like isoform X4
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like, transcript variant X6
translation initiation factor IF-2-like, transcript variant X5
interleukin 2 receptor subunit gamma, transcript variant X1
interleukin 2 receptor subunit gamma, transcript variant X2
cytokine receptor common subunit gamma isoform X2
cytokine receptor common subunit gamma isoform X1
mediator complex subunit 12, transcript variant X1
mediator complex subunit 12, transcript variant X2
mediator complex subunit 12, transcript variant X3
mediator of RNA polymerase II transcription subunit 12 isoform X1
mediator of RNA polymerase II transcription subunit 12 isoform X2
mediator of RNA polymerase II transcription subunit 12 isoform X3
gap junction protein beta 1, transcript variant X3
gap junction protein beta 1, transcript variant X4
gap junction protein beta 1, transcript variant X5
gap junction protein beta 1, transcript variant X2
gap junction protein beta 1, transcript variant X1
zinc finger MYM-type containing 3, transcript variant X7
zinc finger MYM-type containing 3, transcript variant X3
zinc finger MYM-type containing 3, transcript variant X1
zinc finger MYM-type containing 3, transcript variant X6
zinc finger MYM-type containing 3, transcript variant X2
zinc finger MYM-type containing 3, transcript variant X5
zinc finger MYM-type containing 3, transcript variant X9
zinc finger MYM-type containing 3, transcript variant X8
zinc finger MYM-type containing 3, transcript variant X4
zinc finger MYM-type protein 3 isoform X3
zinc finger MYM-type protein 3 isoform X2
zinc finger MYM-type protein 3 isoform X1
non-POU domain containing octamer binding, transcript variant X5
non-POU domain containing octamer binding, transcript variant X6
non-POU domain containing octamer binding, transcript variant X1
non-POU domain containing octamer binding, transcript variant X2
non-POU domain containing octamer binding, transcript variant X3
non-POU domain containing octamer binding, transcript variant X4
non-POU domain-containing octamer-binding protein isoform X1
non-POU domain-containing octamer-binding protein isoform X2
non-POU domain-containing octamer-binding protein isoform X3
non-POU domain-containing octamer-binding protein isoform X4
integrin subunit beta 1 binding protein 2
rho-related GTP-binding protein RhoG-like, transcript variant X3
rho-related GTP-binding protein RhoG-like, transcript variant X1
rho-related GTP-binding protein RhoG-like, transcript variant X2
rho-related GTP-binding protein RhoG-like, transcript variant X4
rho-related GTP-binding protein RhoG-like
TATA-box binding protein associated factor 1, transcript variant X1
TATA-box binding protein associated factor 1, transcript variant X2
TATA-box binding protein associated factor 1, transcript variant X3
TATA-box binding protein associated factor 1, transcript variant X4
transcription initiation factor TFIID subunit 1 isoform X1
transcription initiation factor TFIID subunit 1 isoform X2
transcription initiation factor TFIID subunit 1 isoform X3
transcription initiation factor TFIID subunit 1 isoform X4
TATA-box binding protein associated factor 1, transcript variant X5
transcription initiation factor TFIID subunit 1 isoform X5
O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X3
O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X1
O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
BRCA1/BRCA2-containing complex subunit 3
C-X9-C motif containing 4, transcript variant X4
C-X9-C motif containing 4, transcript variant X5
C-X9-C motif containing 4, transcript variant X1
C-X9-C motif containing 4, transcript variant X2
cx9C motif-containing protein 4 isoform X1
cx9C motif-containing protein 4 isoform X2
mature T cell proliferation 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
mature T cell proliferation 1, transcript variant X2
C-X9-C motif containing 4, transcript variant X3
cx9C motif-containing protein 4 isoform X3
H/ACA ribonucleoprotein complex subunit DKC1
COORDINATES: nucleotide motif:Rfam:12.0:RF00137
COORDINATES: nucleotide motif:Rfam:12.0:RF00567
COORDINATES: nucleotide motif:Rfam:12.0:RF00340
LOW QUALITY PROTEIN: tRNA (uracil(54)-C(5))-methyltransferase homolog
centromere protein I, transcript variant X1
centromere protein I, transcript variant X2
dystrophin related protein 2, transcript variant X2
dystrophin related protein 2, transcript variant X1
dystrophin related protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
dystrophin related protein 2, transcript variant X4
aryl-hydrocarbon-interacting protein-like 1, transcript variant X2
aryl-hydrocarbon-interacting protein-like 1, transcript variant X1
aryl-hydrocarbon-interacting protein-like 1 isoform X2
aryl-hydrocarbon-interacting protein-like 1 isoform X1
TATA-box binding protein associated factor 7 like
transcription initiation factor TFIID subunit 7-like
translocase of inner mitochondrial membrane 8A
mitochondrial import inner membrane translocase subunit Tim8 A
glycine receptor subunit alpha-4, transcript variant X2
glycine receptor subunit alpha-4, transcript variant X1
glycine receptor subunit alpha-4 isoform X2
glycine receptor subunit alpha-4 isoform X1
proteolipid protein 1, transcript variant X1
proteolipid protein 1, transcript variant X2
RAB9B, member RAS oncogene family, transcript variant X1
RAB9B, member RAS oncogene family, transcript variant X3
RAB9B, member RAS oncogene family, transcript variant X2
RAB9B, member RAS oncogene family, transcript variant X4
phosphoribosyl pyrophosphate synthetase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
FERM and PDZ domain containing 3, transcript variant X2
FERM and PDZ domain containing 3, transcript variant X4
FERM and PDZ domain containing 3, transcript variant X1
FERM and PDZ domain containing 3, transcript variant X3
FERM and PDZ domain containing 3, transcript variant X5
FERM and PDZ domain-containing protein 3 isoform X1
FERM and PDZ domain-containing protein 3 isoform X2
FERM and PDZ domain-containing protein 3 isoform X3
dynein axonemal assembly factor 6, transcript variant X4
dynein axonemal assembly factor 6, transcript variant X3
dynein axonemal assembly factor 6, transcript variant X1
dynein axonemal assembly factor 6, transcript variant X6
dynein axonemal assembly factor 6, transcript variant X5
dynein axonemal assembly factor 6, transcript variant X2
dynein axonemal assembly factor 6 isoform X1
dynein axonemal assembly factor 6 isoform X2
proline rich and Gla domain 3, transcript variant X10
proline rich and Gla domain 3, transcript variant X1
proline rich and Gla domain 3, transcript variant X9
proline rich and Gla domain 3, transcript variant X13
proline rich and Gla domain 3, transcript variant X3
proline rich and Gla domain 3, transcript variant X5
proline rich and Gla domain 3, transcript variant X7
proline rich and Gla domain 3, transcript variant X14
proline rich and Gla domain 3, transcript variant X12
proline rich and Gla domain 3, transcript variant X6
proline rich and Gla domain 3, transcript variant X11
proline rich and Gla domain 3, transcript variant X2
proline rich and Gla domain 3, transcript variant X4
proline rich and Gla domain 3, transcript variant X8
transmembrane gamma-carboxyglutamic acid protein 3
mitochondrial fission factor homolog A-like
cyclic nucleotide gated channel subunit alpha 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclic nucleotide-gated olfactory channel
zona pellucida sperm-binding protein 3-like
gamma-aminobutyric acid receptor subunit gamma-4
gamma-aminobutyric acid receptor subunit alpha-3-like
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-4, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-4 isoform X1
gamma-aminobutyric acid receptor subunit beta-4 isoform X2
uncharacterized LOC125333463, transcript variant X1
uncharacterized LOC125333463, transcript variant X2
neuronal migration protein doublecortin isoform X4
neuronal migration protein doublecortin isoform X3
neuronal migration protein doublecortin isoform X2
neuronal migration protein doublecortin isoform X1
serine rich and transmembrane domain containing 2
serine-rich and transmembrane domain-containing 2
ALG13 UDP-N-acetylglucosaminyltransferase subunit
putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13
transient receptor potential cation channel subfamily C member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
short transient receptor potential channel 5
ATPase copper transporting alpha, transcript variant X3
ATPase copper transporting alpha, transcript variant X1
ATPase copper transporting alpha, transcript variant X2
cytochrome c oxidase subunit 7B, mitochondrial
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: magnesium transporter protein 1
ATRX chromatin remodeler, transcript variant X1
ATRX chromatin remodeler, transcript variant X2
transcriptional regulator ATRX isoform X1
transcriptional regulator ATRX isoform X2
zinc finger DHHC-type palmitoyltransferase 15
uracil phosphoribosyltransferase homolog, transcript variant X2
uracil phosphoribosyltransferase homolog, transcript variant X1
uracil phosphoribosyltransferase homolog isoform X2
uracil phosphoribosyltransferase homolog isoform X1
ATP binding cassette subfamily B member 7
iron-sulfur clusters transporter ABCB7, mitochondrial
uncharacterized LOC125333283, transcript variant X1
uncharacterized LOC125333283, transcript variant X2
neurite extension and migration factor, transcript variant X4
neurite extension and migration factor, transcript variant X1
neurite extension and migration factor, transcript variant X2
neurite extension and migration factor, transcript variant X3
ring finger protein, LIM domain interacting, transcript variant X4
ring finger protein, LIM domain interacting, transcript variant X3
ring finger protein, LIM domain interacting, transcript variant X2
ring finger protein, LIM domain interacting, transcript variant X1
E3 ubiquitin-protein ligase RLIM isoform X1
E3 ubiquitin-protein ligase RLIM isoform X2
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X2
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X3
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X1
wiskott-Aldrich syndrome protein family member 3-like isoform X1
wiskott-Aldrich syndrome protein family member 3-like isoform X2
G-protein coupled receptor 12-like, transcript variant X2
G-protein coupled receptor 12-like, transcript variant X1
G-protein coupled receptor 12-like isoform X1
G-protein coupled receptor 12-like isoform X2
ubiquitin carboxyl-terminal hydrolase 12-like
ligand of Numb protein X 2-like, transcript variant X2
ligand of Numb protein X 2-like, transcript variant X1
pre-mRNA 3'-end-processing factor FIP1-like
cysteine rich hydrophobic domain 1, transcript variant X2
cysteine rich hydrophobic domain 1, transcript variant X1
cysteine-rich hydrophobic domain-containing protein 1 isoform X2
cysteine-rich hydrophobic domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
vascular endothelial growth factor receptor kdr-like, transcript variant X2
vascular endothelial growth factor receptor kdr-like, transcript variant X1
vascular endothelial growth factor receptor kdr-like isoform X2
vascular endothelial growth factor receptor kdr-like isoform X1
Cdc42 guanine nucleotide exchange factor 9, transcript variant X4
Cdc42 guanine nucleotide exchange factor 9, transcript variant X1
Cdc42 guanine nucleotide exchange factor 9, transcript variant X14
Cdc42 guanine nucleotide exchange factor 9, transcript variant X10
Cdc42 guanine nucleotide exchange factor 9, transcript variant X13
Cdc42 guanine nucleotide exchange factor 9, transcript variant X9
Cdc42 guanine nucleotide exchange factor 9, transcript variant X11
Cdc42 guanine nucleotide exchange factor 9, transcript variant X12
Cdc42 guanine nucleotide exchange factor 9, transcript variant X8
Cdc42 guanine nucleotide exchange factor 9, transcript variant X7
rho guanine nucleotide exchange factor 9 isoform X3
rho guanine nucleotide exchange factor 9 isoform X1
rho guanine nucleotide exchange factor 9 isoform X9
rho guanine nucleotide exchange factor 9 isoform X10
rho guanine nucleotide exchange factor 9 isoform X11
rho guanine nucleotide exchange factor 9 isoform X7
rho guanine nucleotide exchange factor 9 isoform X8
rho guanine nucleotide exchange factor 9 isoform X6
rho guanine nucleotide exchange factor 9 isoform X12
Cdc42 guanine nucleotide exchange factor 9, transcript variant X5
Cdc42 guanine nucleotide exchange factor 9, transcript variant X3
Cdc42 guanine nucleotide exchange factor 9, transcript variant X2
rho guanine nucleotide exchange factor 9 isoform X4
rho guanine nucleotide exchange factor 9 isoform X2
Cdc42 guanine nucleotide exchange factor 9, transcript variant X6
rho guanine nucleotide exchange factor 9 isoform X5
ankyrin repeat and SOCS box containing 12, transcript variant X2
ankyrin repeat and SOCS box containing 12, transcript variant X1
myotubularin related protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myotubularin related protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myotubularin related protein 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
myotubularin-related protein 8 isoform X2
myotubularin-related protein 8 isoform X1
myotubularin-related protein 8 isoform X3
chromosome 14 C8orf48 homolog, transcript variant X3
chromosome 14 C8orf48 homolog, transcript variant X4
chromosome 14 C8orf48 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromosome 14 C8orf48 homolog, transcript variant X6
chromosome 14 C8orf48 homolog, transcript variant X2
chromosome 14 C8orf48 homolog, transcript variant X1
uncharacterized protein C8orf48 homolog isoform X2
uncharacterized protein C8orf48 homolog isoform X3
uncharacterized protein C8orf48 homolog isoform X1
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ras-related GTP-binding protein A, transcript variant X3
ras-related GTP-binding protein A, transcript variant X1
ras-related GTP-binding protein A isoform X1
ras-related GTP-binding protein A isoform X3
ras-related GTP-binding protein A, transcript variant X2
ras-related GTP-binding protein A isoform X2
Kruppel like factor 8, transcript variant X2
Kruppel like factor 8, transcript variant X3
Kruppel like factor 8, transcript variant X5
Kruppel like factor 8, transcript variant X1
Kruppel like factor 8, transcript variant X4
Krueppel-like factor 5, transcript variant X2
Krueppel-like factor 5, transcript variant X1
BTB/POZ domain-containing protein KCTD12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
LOW QUALITY PROTEIN: exocyst complex component 1-like
glyoxalase domain containing 5, transcript variant X2
glyoxalase domain containing 5, transcript variant X1
glyoxalase domain-containing protein 5 isoform X1
glyoxalase domain-containing protein 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
NAD(P) dependent steroid dehydrogenase-like, transcript variant X1
NAD(P) dependent steroid dehydrogenase-like, transcript variant X3
NAD(P) dependent steroid dehydrogenase-like, transcript variant X2
NAD(P) dependent steroid dehydrogenase-like, transcript variant X4
NAD(P) dependent steroid dehydrogenase-like, transcript variant X5
sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X1
sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X2
zinc finger protein 185 with LIM domain, transcript variant X1
zinc finger protein 185 with LIM domain, transcript variant X5
zinc finger protein 185 with LIM domain, transcript variant X2
zinc finger protein 185 with LIM domain, transcript variant X3
zinc finger protein 185 with LIM domain, transcript variant X4
zinc finger protein 185 with LIM domain, transcript variant X8
zinc finger protein 185 with LIM domain, transcript variant X7
zinc finger protein 185 with LIM domain, transcript variant X6
SLAIN motif-containing protein-like, transcript variant X1
SLAIN motif-containing protein-like, transcript variant X3
SLAIN motif-containing protein-like, transcript variant X2
SLAIN motif-containing protein-like isoform X1
SLAIN motif-containing protein-like isoform X2
vesicle associated membrane protein 7, transcript variant X1
vesicle associated membrane protein 7, transcript variant X2
DNA-directed RNA polymerases I and III subunit RPAC2-like
endothelin receptor type B-like, transcript variant X1
endothelin receptor type B-like, transcript variant X2
endothelin receptor type B-like isoform X1
endothelin receptor type B-like isoform X2
brain-specific homeobox/POU domain protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sprouty RTK signaling antagonist 3, transcript variant X2
sprouty RTK signaling antagonist 3, transcript variant X3
sprouty RTK signaling antagonist 3, transcript variant X1
trimethyllysine hydroxylase, epsilon, transcript variant X2
trimethyllysine hydroxylase, epsilon, transcript variant X3
trimethyllysine hydroxylase, epsilon, transcript variant X1
trimethyllysine dioxygenase, mitochondrial isoform X1
trimethyllysine dioxygenase, mitochondrial isoform X2
tumor necrosis factor ligand superfamily member 10-like
H(+)/Cl(-) exchange transporter 5, transcript variant X6
H(+)/Cl(-) exchange transporter 5, transcript variant X1
H(+)/Cl(-) exchange transporter 5, transcript variant X5
H(+)/Cl(-) exchange transporter 5, transcript variant X4
H(+)/Cl(-) exchange transporter 5, transcript variant X3
H(+)/Cl(-) exchange transporter 5, transcript variant X2
H(+)/Cl(-) exchange transporter 5, transcript variant X7
H(+)/Cl(-) exchange transporter 5 isoform X1
H(+)/Cl(-) exchange transporter 5 isoform X3
H(+)/Cl(-) exchange transporter 5 isoform X2
H(+)/Cl(-) exchange transporter 5 isoform X4
regulator of cell cycle RGCC-like, transcript variant X2
regulator of cell cycle RGCC-like, transcript variant X1
Rho GTPase activating protein 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Rho GTPase activating protein 36, transcript variant X3
Rho GTPase activating protein 36, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
rho GTPase-activating protein 36 isoform X1
rho GTPase-activating protein 36 isoform X2
ecto-NOX disulfide-thiol exchanger 2, transcript variant X5
ecto-NOX disulfide-thiol exchanger 2, transcript variant X4
ecto-NOX disulfide-thiol exchanger 2, transcript variant X3
ecto-NOX disulfide-thiol exchanger 2, transcript variant X1
ecto-NOX disulfide-thiol exchanger 2, transcript variant X2
ecto-NOX disulfide-thiol exchanger 2 isoform X2
ecto-NOX disulfide-thiol exchanger 2 isoform X1
ecto-NOX disulfide-thiol exchanger 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
glucose-dependent insulinotropic receptor
methionine--tRNA ligase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
apoptosis inducing factor mitochondria associated 1, transcript variant X1
apoptosis inducing factor mitochondria associated 1, transcript variant X2
apoptosis-inducing factor 1, mitochondrial isoform X1
apoptosis-inducing factor 1, mitochondrial isoform X2
UTP14A small subunit processome component, transcript variant X2
UTP14A small subunit processome component, transcript variant X1
U3 small nucleolar RNA-associated protein 14 homolog A isoform X2
U3 small nucleolar RNA-associated protein 14 homolog A isoform X1
zinc finger DHHC-type palmitoyltransferase 9
SAM and SH3 domain containing 3, transcript variant X3
SAM and SH3 domain containing 3, transcript variant X2
SAM and SH3 domain containing 3, transcript variant X1
SAM and SH3 domain-containing protein 3 isoform X3
SAM and SH3 domain-containing protein 3 isoform X2
SAM and SH3 domain-containing protein 3 isoform X1
X-prolyl aminopeptidase 2, transcript variant X2
X-prolyl aminopeptidase 2, transcript variant X1
OCRL inositol polyphosphate-5-phosphatase, transcript variant X2
OCRL inositol polyphosphate-5-phosphatase, transcript variant X4
OCRL inositol polyphosphate-5-phosphatase, transcript variant X3
OCRL inositol polyphosphate-5-phosphatase, transcript variant X1
inositol polyphosphate 5-phosphatase OCRL isoform X2
inositol polyphosphate 5-phosphatase OCRL isoform X4
inositol polyphosphate 5-phosphatase OCRL isoform X3
inositol polyphosphate 5-phosphatase OCRL isoform X1
ERCC excision repair 6 like, spindle assembly checkpoint helicase
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
probable E3 ubiquitin-protein ligase MID2
TSC22 domain family member 3, transcript variant X1
TSC22 domain family protein 3 isoform X1
TSC22 domain family member 3, transcript variant X2
TSC22 domain family protein 3 isoform X2
fatty acid amide hydrolase 2, transcript variant X1
fatty acid amide hydrolase 2, transcript variant X2
fatty acid amide hydrolase 2, transcript variant X3
fatty acid amide hydrolase 2, transcript variant X5
fatty acid amide hydrolase 2, transcript variant X4
interferon lambda receptor 1-like, transcript variant X3
interferon lambda receptor 1-like, transcript variant X2
interferon lambda receptor 1-like, transcript variant X4
interferon lambda receptor 1-like, transcript variant X1
interferon lambda receptor 1-like, transcript variant X6
interferon lambda receptor 1-like, transcript variant X7
interferon lambda receptor 1-like, transcript variant X5
interferon lambda receptor 1-like isoform X1
interferon lambda receptor 1-like isoform X2
interferon lambda receptor 1-like isoform X3
interferon lambda receptor 1-like, transcript variant X10
interferon lambda receptor 1-like, transcript variant X9
interferon lambda receptor 1-like, transcript variant X8
uncharacterized protein LOC125333017 isoform X4
chloride intracellular channel protein 2-like
protein eva-1 homolog C-like, transcript variant X2
protein eva-1 homolog C-like, transcript variant X1
protein eva-1 homolog C-like, transcript variant X4
protein eva-1 homolog C-like, transcript variant X3
G2/mitotic-specific cyclin-B3 isoform X3
G2/mitotic-specific cyclin-B3 isoform X1
G2/mitotic-specific cyclin-B3 isoform X2
LOW QUALITY PROTEIN: diacylglycerol kinase delta-like
protein Shroom4-like, transcript variant X4
protein Shroom4-like, transcript variant X3
protein Shroom4-like, transcript variant X2
protein Shroom4-like, transcript variant X1
protein Shroom4-like, transcript variant X6
protein Shroom4-like, transcript variant X5
protein Shroom4-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
phosphorylase kinase regulatory subunit alpha 1, transcript variant X1
phosphorylase kinase regulatory subunit alpha 1, transcript variant X3
phosphorylase kinase regulatory subunit alpha 1, transcript variant X5
phosphorylase kinase regulatory subunit alpha 1, transcript variant X6
phosphorylase kinase regulatory subunit alpha 1, transcript variant X4
phosphorylase kinase regulatory subunit alpha 1, transcript variant X2
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X1
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X2
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X4
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X3
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X5
histone deacetylase 8, transcript variant X2
histone deacetylase 8, transcript variant X1
histone deacetylase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
histone deacetylase 8, transcript variant X4
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: splicing regulator RBM11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns